Presence of ovarian stromal aberrations after cessation of testosterone therapy in a transgender mouse model†.
Ontology highlight
ABSTRACT: Some transmasculine individuals may be interested in pausing gender-affirming testosterone therapy and carrying a pregnancy. The ovarian impact of taking and pausing testosterone is not completely understood. The objective of this study was to utilize a mouse model mimicking transmasculine testosterone therapy to characterize the ovarian dynamics following testosterone cessation. We injected postpubertal 9-10-week-old female C57BL/6N mice once weekly with 0.9 mg of testosterone enanthate or a vehicle control for 6 weeks. All testosterone-treated mice stopped cycling and demonstrated persistent diestrus within 1 week of starting testosterone, while control mice cycled regularly. After 6 weeks of testosterone therapy, one group of testosterone-treated mice and age-matched vehicle-treated die
SUBMITTER: Kinnear HM
PROVIDER: S-EPMC10183359 | biostudies-literature | 2023 May
REPOSITORIES: biostudies-literature
ACCESS DATA